• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

朝鲜日益严重的耐多药结核病问题。

The growing problem of multidrug-resistant tuberculosis in North Korea.

机构信息

Eugene Bell Foundation, Washington, DC, United States of America.

出版信息

PLoS Med. 2013;10(7):e1001486. doi: 10.1371/journal.pmed.1001486. Epub 2013 Jul 30.

DOI:10.1371/journal.pmed.1001486
PMID:23935457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3727921/
Abstract

Kwonjune Seung and Stephen Linton from the non-governmental organization EugeneBell discuss the worryingly high levels of multidrug-resistant tuberculosis they have observed in North Korea's tuberculosis sanatoria.

摘要

韩国非政府组织 EugeneBell 的权俊仁（音译）和斯蒂芬·林顿讨论了他们在朝鲜结核病疗养院观察到的令人担忧的高水平耐多药结核病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/3727921/c224c660111d/pmed.1001486.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/3727921/c224c660111d/pmed.1001486.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d8/3727921/c224c660111d/pmed.1001486.g001.jpg

相似文献

1
The growing problem of multidrug-resistant tuberculosis in North Korea.朝鲜日益严重的耐多药结核病问题。
PLoS Med. 2013;10(7):e1001486. doi: 10.1371/journal.pmed.1001486. Epub 2013 Jul 30.
2
Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?朝鲜的耐多药结核病治疗：扩大规模是否可行？
PLoS Med. 2016 Aug 2;13(8):e1002062. doi: 10.1371/journal.pmed.1002062. eCollection 2016 Aug.
3
Characteristics of Drug Resistant Tuberculosis in Sanatoria of North Korea.朝鲜疗养院耐药结核病的特征
J Korean Med Sci. 2017 Jul;32(7):1105-1110. doi: 10.3346/jkms.2017.32.7.1105.
4
Tuberculosis in North Korea.朝鲜的结核病
Science. 2011 Jan 21;331(6015):263. doi: 10.1126/science.1201892.
5
Public enemy number one.头号公敌。
Science. 2013 Apr 26;340(6131):422-5. doi: 10.1126/science.340.6131.422.
6
Drug-resistant tuberculosis: reality and potential threat.耐药结核病：现状与潜在威胁
Int J Tuberc Lung Dis. 2010 Mar;14(3):255-8.
7
North Korea. New tuberculosis lab hailed as breakthrough in health diplomacy.朝鲜。新的结核病实验室被誉为卫生外交的一项突破。
Science. 2010 Mar 12;327(5971):1312-3. doi: 10.1126/science.327.5971.1312-b.
8
Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005-2009.2005 - 2009年，巴基斯坦耐氟喹诺酮结核分枝杆菌
Emerg Infect Dis. 2011 Mar;17(3):564-6. doi: 10.3201/eid1703.100957.
9
Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.药物敏感型与再激活潜伏多药耐药结核分枝杆菌的合并感染
Emerg Infect Dis. 2015 Nov;21(11):2098-100. doi: 10.3201/eid2111.150683.
10
Emerging epidemic of drug resistant tuberculosis in vulnerable populations of developing countries.发展中国家弱势群体中耐药结核病的新流行情况。
Afr Health Sci. 2017 Jun;17(2):599-602. doi: 10.4314/ahs.v17i2.40.

引用本文的文献

1
Discrepancies in tuberculosis burden estimates: North Korean defectors vs. official reports.结核病负担估计的差异：朝鲜脱北者与官方报告对比
Front Public Health. 2025 May 30;13:1545628. doi: 10.3389/fpubh.2025.1545628. eCollection 2025.
2
High-Accuracy Long-Read Sequencing of PSNK363 Isolated From the Democratic People's Republic of Korea.从朝鲜分离出的PSNK363的高精度长读长测序
Can J Infect Dis Med Microbiol. 2025 Feb 11;2025:2234550. doi: 10.1155/cjid/2234550. eCollection 2025.
3
Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model.

本文引用的文献

1
Tuberculosis in North Korea.朝鲜的结核病
Science. 2011 Jan 21;331(6015):263. doi: 10.1126/science.1201892.
2
Does my patient have multidrug-resistant tuberculosis?我的患者患有耐多药结核病吗？
Clin Infect Dis. 2010 Aug 15;51(4):379-80. doi: 10.1086/655128.
3
North Korea's fight against tuberculosis gets a boost.朝鲜抗击结核病的行动得到了推动。
利用数学模型预测南、北朝鲜控制策略对结核病负担的影响。
BMJ Glob Health. 2021 Oct;6(10). doi: 10.1136/bmjgh-2021-005953.
4
Surgical Diseases in North Korea: An Overview of North Korean Medical Journals.朝鲜的外科疾病：朝鲜医学期刊概述。
Int J Environ Res Public Health. 2020 Dec 14;17(24):9346. doi: 10.3390/ijerph17249346.
5
Towards Understanding Tuberculosis-Related Issues in North Korea: A Narrative Review of North Korean Literature.理解朝鲜的结核病相关问题：对朝鲜文献的叙述性综述
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):201-210. doi: 10.4046/trd.2019.0070. Epub 2020 Mar 10.
6
Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees.朝鲜难民潜伏性结核感染治疗的经验
Tuberc Respir Dis (Seoul). 2019 Oct;82(4):306-310. doi: 10.4046/trd.2019.0034. Epub 2019 May 31.
7
Systematic review of evidence on public health in the Democratic People's Republic of Korea.朝鲜公共卫生证据的系统评价。
BMJ Glob Health. 2019 Mar 9;4(2):e001133. doi: 10.1136/bmjgh-2018-001133. eCollection 2019.
8
Epidemiology survey of infectious diseases in North Korean travelers, 2015-2017.2015-2017 年朝鲜旅行者传染病的流行病学调查。
BMC Infect Dis. 2019 Jan 5;19(1):13. doi: 10.1186/s12879-018-3664-x.
9
Characteristics of Drug Resistant Tuberculosis in Sanatoria of North Korea.朝鲜疗养院耐药结核病的特征
J Korean Med Sci. 2017 Jul;32(7):1105-1110. doi: 10.3346/jkms.2017.32.7.1105.
10
Rights-Based TB Programs for Migrants and Prisoners Needed in North Korea.朝鲜需要为移民和囚犯制定基于权利的结核病防治项目。
Health Hum Rights. 2016 Jun;18(1):109-114.
BMJ. 2010 Apr 22;340:c2223. doi: 10.1136/bmj.c2223.
4
Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.初始耐药性与结核病治疗结果：系统评价与荟萃分析
Ann Intern Med. 2008 Jul 15;149(2):123-34. doi: 10.7326/0003-4819-149-2-200807150-00008.
5
The Global Drug Facility: a unique, holistic and pioneering approach to drug procurement and management.全球药品设施：一种独特、全面且开创性的药品采购与管理方法。
Bull World Health Organ. 2007 May;85(5):348-53. doi: 10.2471/blt.06.035402.
6
Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.在耐药水平较高地区进行短程直接观察治疗结核病期间获得性耐药的风险。
Clin Infect Dis. 2007 Jun 1;44(11):1421-7. doi: 10.1086/517536. Epub 2007 Apr 24.
7
The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.初始耐药对结核病标准化短程化疗期间治疗反应及获得性耐药的影响。
Clin Infect Dis. 2004 Nov 1;39(9):1321-8. doi: 10.1086/425005. Epub 2004 Oct 13.
8
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.采用标准化短程化疗“成功”治疗的耐多药结核病病例的复发频率。
Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.
9
Managerial successes, clinical failures.管理上的成功，临床上的失败。
Int J Tuberc Lung Dis. 1999 May;3(5):365-7.